MORE►
iC3 Life Science Summit
The 2024 BioNTX iC3 Summit will be held Oct. 3-4 at the new Loews Arlington Convention Center in Arlington, which is connected to the Loews Arlington Hotel in the heart of the city's Entertainment District. [Image: Loews Arlington Hotel]
10th Annual iC3 Summit: BioNTX Brings Life Science Leaders to Brand-New Loews Arlington Venue in October
by Lance Murray | Jun 17, 2024
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization,—underscores its mission to drive breakthroughs through strategic partnerships and investments.
The 2024 iC3 Summit, hosted by nonprofit BioNTX, is set to welcome over 1,000 industry professionals, researchers, entrepreneurs, and investors for its largest gathering yet. The event's formula—Innovation = Capital × Collaboration × Commercialization—underscores its mission to drive breakthroughs through strategic partnerships and investments.
by Quincy Preston |
Sep 28, 2023
With a theme of “Innovation, Capital, Collaboration, Commercialization”—or iC³—the summit unites researchers, entrepreneurs, investors, corporations, and support organizations to forge the relationships that drive progress.
MORE►
by Quincy Preston |
Sep 14, 2023
The North Texas bioscience organization, a driving force for growth in the regional ecosystem, will convene leaders at its flagship conference to catalyze industry opportunities, spotlight emerging companies, and make connections.
See who made this year's Rising Stars list—and how you can attend the summit.
See who made this year's Rising Stars list—and how you can attend the summit.
MORE►
by Kevin Cummings |
Sep 26, 2022
After a rigorous process, the top six applications to the Tech Transfer Office Showcase at BioNTX's iC3 life science summit were invited to pitch live at BioNTX's life science summit. Industry experts rated, graded, and discussed the technologies prior to the pitches
"We want to cultivate technologies that are coming out of the university ecosystem here—and we want them to stay here," said Chad Ronholdt, managing director at NVB Ventures.
MORE►
Paul Dorman, Chairman and CEO of DFB Pharmaceuticals, assembled a team of internal and external experts after launching NanOlogy in a partnership with CritiTech and US Biotest in 2015. [Source photo: BioNTX]
BionorthTX Names Pharma Entrepreneur, Investor, and Philanthropist as Stone Award Recipient
by Lance Murray | Sep 9, 2019
Among the contributions of recipient Paul Dorman, the chairman and CEO of DFB Pharmaceuticals, is paying for the first-year tuition of the entire inaugural class of M.D. students at the TCU and UNTHSC School of Medicine in Fort Worth.
MORE►
by bionorthTX |
Sep 24, 2018
The recipient of the Dennis K. Stone Life Science Achievement Award has not yet been announced.
MORE►
by Nicholas Sakelaris |
Oct 13, 2017
From the future of Cancer Prevention & Research Institute of Texas grants to patient records innovation, leaders discussed issues facing the industry.
MORE►
by D'Anzia Robertson |
Oct 13, 2017
BionorthTX's annual summit brought industry leaders together to discuss the future of health care and impact of new technology.
MORE►
Illustration: ClaudioVentrella via iStock
Biotechnology Experts Converge at 2nd Annual IC3 Life Science Summit
by Nicholas Sakelaris | Oct 27, 2016
Advances in technology are revolutionizing healthcare, changing the entire business model for how doctors treat patients.
MORE►
by Heather Noel |
Oct 4, 2016
The life science industry association has more than 70 North Texas companies and 20 individuals or job seekers within its membership.
MORE►
